Key result
A genome-wide CRISPR-Cas9 knockout screen identified eIF2A as a host factor that specifically and directly enhances SARS-CoV-2 programmed -1 ribosomal frameshifting and viral replication.
Why the study?
Many positive-strand RNA viruses employ programmed -1 ribosomal frameshifting (-1 PRF) to regulate translation, but only a few host factors have been shown to regulate -1 PRF.
The noncanonical translation factor eIF2A is identified as a crucial host factor that enhances SARS-CoV-2 programmed -1 ribosomal frameshifting, presenting a potential target for reducing viral replication.
eIF2A and other host factors modulate SARS-CoV-2 -1 PRF; leaves open host-directed antiviral strategies pending functional validation.
Many positive-strand RNA viruses, including all known coronaviruses, employ programmed -1 ribosomal frameshifting (-1 PRF) to regulate the translation of polycistronic viral RNAs. However, only a few host factors have been shown to regulate -1 PRF. Through a genome-wide CRISPR-Cas9 knockout screen, we have identified host factors that either suppress or enhance severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) -1 PRF. Among them, eukaryotic translation initiation factor 2A (eIF2A) specifically and directly enhances -1 PRF independent of changes in initiation. Consistent with the crucial role of efficient -1 PRF in transcriptase/replicase expression, loss of eIF2A reduces SARS-CoV-2 replication in cells. Furthermore, transcriptome-wide analysis shows that eIF2A preferentially binds CG-rich RNA motifs, including a region within 18S ribosomal RNA near the contacts between the SARS-CoV-2 frameshift-stimulatory element (FSE) and the ribosome. Thus, our results indicate a role for eIF2A in modulating the translation of specific RNAs independent of its role during initiation.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2023) studied SARS-CoV-2. eIF2A knockout via CRISPR-Cas9 was evaluated on SARS-CoV-2 programmed -1 ribosomal frameshifting and viral replication. A genome-wide CRISPR-Cas9 knockout screen identified eIF2A as a host factor that specifically and directly enhances SARS-CoV-2 programmed -1 ribosomal frameshifting and viral replication.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: